The order is carried out as a part of the project titled:
DUBs: „RESEARCH AND DEVELOPMENT OF DEUBIQUITINASE INHIBITORS IN ANTITUMOR IMMUNOTHERAPY” (POIR.01.01.01-00-0615/19)
co-financed by European Union Funds and because of the competitiveness principle.
We hereby look for Contractor ready to perform:
Research service related to the study of the impact of our compound on 100 cell lines with diverse genetic background and origin (derived from different tumour types) in order to define genetic profile that potentially determines resistance/sensitivness of the model to compound and bioinformatics analysis of „responder vs non-responder group.
On January 24, 2022, Ordering Party updated the Request for the proposal regarding the deadline for offers submitting. Changes were marked in red and crossed out. The deadline for offers submitting was extended to February 4, 2022.